[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing




..
:: Volume 1, Issue 4 (12-2025) ::
Journalaer 2025, 1(4): 41-44 Back to browse issues page
Effect of Morphine administration on content of short-chain fatty acid of human gut microbiota
Mohammad Reza Barzegar , Mohsen Zargar * , Seyed Davar Siadat , Farzam Vaziri , Razieh Nazari
Abstract:   (849 Views)
Introduction: In addition to mental and spiritual problems, drug addiction affects the addict’s physical health. The digestive system is a key body system that contains plenty of opioid receptors, which makes it vulnerable to these compounds.
Materials & Methods: The present study is an attempt to study the effects of morphine on short chain fatty acid levels produced by the intestine microbiota. 30 healthy individuals and 30 oral users of opium (for six years with a mean daily intake of 0.8 gr) were recruited. All the participants were men with a mean age of 40±3.9 years. The mean period of consuming drugs in the drug addicts was six years. After sampling feces of the participants, the level of fatty acids, including acetate, propionate, and butyrate were measured through gas chematography-flame ionization detection.

Results: The results indicated that compared to the healthy participants, the drug addict group had a significantly higher acetate (97.91 vs. 76.2), propionate (25.91 vs. 19.28), and butyrate (25.36 vs. 19.68) level (µm/g).
Conclusion: In general, the results indicated that consuming morphine can affect production of short chain fatty acids. This can be attributed to the changes in microbiota of the digestive system of the consumers.
Keywords: Morphine, Drug addict, Feces, Microbiota, Fatty acid
Full-Text [PDF 568 kb]   (338 Downloads)    
Type of Study: Research | Subject: General
Received: 2025/10/6 | Accepted: 2025/09/1 | Published: 2025/12/2
References
1. 1. Esmaeili, N.A., Khodadadi, A. and, Sayadi, A.A.R., 2004. The effect of narcotics on blood sugar, triglycerides and cholesterol in drug-dependants. Journal of Sabzevar University of Medical Sciences. 10(4): 13-19. (In Persian)
2. 2. Mohammadi, A., Darabi, M., Nasry, M., Saabet Jahromi, M.J., Malek-Pour-Afshar, R. and Sheibani, H., 2009. Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. Experimental and toxicologic pathology. 61(2): 145-149. doi: 10.1016/ j.etp.2008.08.001
3. 3. Plein, L.M. and Rittner, H.L., 2018. Opioids and the immune system–friend or foe. British journal of pharmacology. 175(14): 2717-2725. doi: 10.1111/bph. 13750
4. 4. Bagheripoor, M., Khazali, H., Mahmoudi, F. and Samiee, K., 2018. The effects of morphine sulphate on hypothalamic glutamate levels and serum LH hormone concentration in male rats. Journal of Animal Environment. 10(2): 45-50. (In Persian)
5. 5. Haghnazari, F., Khazali, H. and Taghvimi, S., 2016. Galanin or morphine significantly decreased thyroid hormones concentration after injections compared to before injection. Journal of Animal Environment. 8(2): 47-52. (In Persian)
6. 6. Shavakhy, A., Sadeghi, A.R. and Minakary, M., 2010. Opium Consumption and Risk of Liver Fibrosis in Chronic Hepatitis B and C. Journal of Isfahan Medical School. 28(110): 19-25. (In Persian)
7. 7. Lewis, K., Lutgendorff, F., Phan, V., Söderholm, J.D., Sherman, P.M. and McKay, D.M., 2010. Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflammatory bowel diseases. 16(7): 1138-1148. doi: 10.1002/ibd.21177
8. 8. Gaudier, E., Rival, M., Buisine, M.P., Robineau, I. and Hoebler, C., 2009. Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. Physiological research. 58(1): 111-119. doi: 10.33549/physiolres.931271
9. 9. Habibian, S., Zamani Ahmadmahmoodi, M., Shad khast, M., Khaksar, E., Rashidi, M. and Ziaei, B., 2011. Effect of Chronic Administration of Opioids (Morphine) on Growth and Intestinal Mucosa in Mouse Strain Balb/c. Veterinary Research (Gar Branmsar Branch). 6: 176-181.
10. 10. Machado, M.G., Sencio, V. and Trottein, F., 2021. Short-chain fatty acids as a potential treatment for infections: a closer look at the lungs. Infection and Immunity. 89(9): e0018821. doi: 10.1128/IAI.00188-21
11. 11. Luu, M., Pautz, S., Kohl, V., Singh, R., Romero, R. and Lucas, S., 2019. The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nature communications. 10(1): 1-12. doi: 10.1038/s41467-019-08711-2
12. 12. Dehghani, S., Rostami, R. and Aslani, S., 2017. Addiction in adolescents: A review on neurological concepts. Rooyesh-e-Ravanshenasi Journal (RRJ). 6(3): 115-134. (In Persian)
13. 13. Barengolts, E., Green, S.J., Eisenberg, Y., Akbar, A., Reddivari, B. and Layden, B.T., 2018. Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease. PLoS One. 13(3): 171-194. doi: 10.1371/ journal.pone.0194171
14. 14. Wang, F. and Roy, S., 2017. Gut homeostasis, microbial dysbiosis, and opioids. Toxicologic pathology. 45(1): 150-156. doi: 10.1177/0192623316679898
15. 15. Schönfeld, P. and Wojtczak, L., 2016. Short and medium chain fatty acids in energy metabolism: the cellular perspective. Journal of lipid research. 57(6): 943-954. doi: 10.1194/jlr.R067629
16. 16. Macfarlane, S. and Macfarlane, G.T., 2003. Regulation of short-chain fatty acid production. Proceedings of the Nutrition Society. 62(1): 67-72. doi: 10.1079/PNS2002207
17. 17. Thomas, K.R., Watt, J., Wu, C.M.J., Akinrinoye, A., Amjad, S. and Colvin, L., 2022. Pain and Opioid-Induced Gut Microbial Dysbiosis. Biomedicines. 10(8): 1815. doi: 10.3390/biomedicines10081815
18. 18. Börnigen, D., Morgan, X.C., Franzosa, E.A., Ren, B., Xavier, R.J. and Garrett, W.S., 2013. Functional profiling of the gut microbiome in disease-associated inflammation. Genome medicine. 5(7): 1-13. doi: 10.1186/gm469
19. 19. Cho, I., Yamanishi, S., Cox, L., Methé, B.A., Zavadil, J. and Li, K., 2012. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 488(7): 621-626. doi: 10.1038/nature11400
20. 20. Kim, H.B., Borewicz, K., White, B.A., Singer, R.S., Sreevatsan, S. and Tu, Z.J., 2012. Microbial shifts in the swine distal gut in response to the treatment with anti microbial growth promoter, tylosin. Proceedings of the National Academy of Sciences. 109(38): 15485-15490. doi: 10.1073/pnas.1205147109
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Barzegar M R, Zargar M, Siadat S D, Vaziri F, Nazari R. Effect of Morphine administration on content of short-chain fatty acid of human gut microbiota. Journalaer 2025; 1 (4) :41-44
URL: http://journalaer.com/article-1-45-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 1, Issue 4 (12-2025) Back to browse issues page
پژوهش های محیط زیست جانوری Journal of Animal Environmental Research
Persian site map - English site map - Created in 0.19 seconds with 39 queries by YEKTAWEB 4774